MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Real-time Boerse Frankfurt Warrants 13:04:41 26/06/2024 BST | ||
| 3.66 EUR | +0.55% |
|
| Current month | +5.20% | ||
| 1 month | -9.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 3.66 | +0.55% |
| 25/06/24 | 3.64 | +9.64% |
| 24/06/24 | 3.32 | -7.52% |
| 21/06/24 | 3.59 | +6.53% |
| 20/06/24 | 3.37 | -9.16% |
Real-time Boerse Frankfurt Warrants
Last update June 26, 2024 at 01:04 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DQ0C3P |
| ISIN | DE000DQ0C3P4 |
| Date issued | 09/02/2024 |
| Strike | 260.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.703 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.7 € |
|---|---|
| Lowest since issue | 1.26 € |
| Spread | 0.06 € |
| Spread % | 1.61% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
223.2
USD
Average target price
283.2
USD
Spread / Average Target
+26.87%
- Stock Market
- Certificates
- Certificat
